Drug Catalog - Product Detail
SILDENAFIL TABS 20MG 90CT
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 65162-0351-09 | AMNEAL PHARMACEUTICALS | 90 | 20MG | TABLET |
PACKAGE FILES
Generic Name
SILDENAFIL
Substance Name
SILDENAFIL CITRATE
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Application Number
ANDA202025
Description
11 DESCRIPTION Sildenafil citrate, phosphodiesterase-5 (PDE-5) inhibitor, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type-5 (PDE-5). Sildenafil is also marketed as VIAGRA ® for erectile dysfunction. Sildenafil citrate is designated chemically as 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1 H -pyrazolo [4,3- d ] pyrimidin-5-yl)-4-ethoxyphenyl] sulfonyl]-4-methylpiperazine citrate and has the following structural formula: Sildenafil citrate, USP is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Sildenafil tablets, USP are formulated as white to off-white, round shaped film-coated tablets for oral administration. Each tablet contains sildenafil citrate, USP equivalent to 20 mg of sildenafil. In addition to the active ingredient, sildenafil citrate, USP, each tablet contains the following inactive ingredients: croscarmellose sodium, dibasic calcium phosphate anhydrous, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, talc and titanium dioxide. 4
How Supplied
16 HOW SUPPLIED/STORAGE AND HANDLING Sildenafil Tablets USP, 20 mg, are supplied as white to off-white, round shaped film-coated tablets with debossing ‘AN 351’ on one side and plain on the other side, containing sildenafil citrate, USP equivalent to the nominally indicated amount of sildenafil. They are available as follows: Bottles of 90: NDC 65162-351-09 Bottles of 1000: NDC 65162-351-11 Recommended Storage for Sildenafil Tablets, USP: Store at controlled room temperature 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Indications & Usage
1 INDICATIONS AND USAGE Adults Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening. New Dosing Regimen in Adults with Pulmonary Arterial Hypertension (PAH) and treatment of PAH in Pediatric Patients (Ages 1 to 17) information are approved for Viatris Specialty LLC’s Revatio (Sildenafil) tablets. However, due to Viatris Specialty LLC’s marketing exclusivity rights, this drug product is not labeled with these information. Adults Sildenafil tablets are a phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening. (1)
Dosage and Administration
2 DOSAGE AND ADMINISTRATION Adults: 20 mg three times a day, 4 to 6 hours apart. (2.1) 2.1 Recommended Dosage in Adults The recommended dosage of sildenafil tablet is 20 mg three times a day. Administer sildenafil tablet doses 4 to 6 hours apart. New Dosing Regimen in Adults with Pulmonary Arterial Hypertension (PAH) and treatment of PAH in Pediatric Patients (Ages 1 to 17) information are approved for Viatris Specialty LLC’s Revatio (Sildenafil) tablets. However, due to Viatris Specialty LLC’s marketing exclusivity rights, this drug product is not labeled with these information.